Raymond James Financial Services Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$973K Buy
7,787
+74
+1% +$9.24K ﹤0.01% 2182
2024
Q2
$1.22M Sell
7,713
-1,371
-15% -$217K ﹤0.01% 1962
2024
Q1
$1.18M Buy
9,084
+109
+1% +$14.1K ﹤0.01% 1961
2023
Q4
$865K Sell
8,975
-974
-10% -$93.9K ﹤0.01% 2068
2023
Q3
$1.21M Sell
9,949
-463
-4% -$56.1K ﹤0.01% 1793
2023
Q2
$1.19M Buy
10,412
+1,012
+11% +$116K ﹤0.01% 1805
2023
Q1
$1.3M Sell
9,400
-6,267
-40% -$864K ﹤0.01% 1740
2022
Q4
$2.03M Buy
15,667
+4,036
+35% +$523K ﹤0.01% 1434
2022
Q3
$1.29M Sell
11,631
-1,012
-8% -$112K ﹤0.01% 1678
2022
Q2
$948K Buy
12,643
+2,806
+29% +$210K ﹤0.01% 1873
2022
Q1
$768K Sell
9,837
-555
-5% -$43.3K ﹤0.01% 2120
2021
Q4
$936K Sell
10,392
-12,132
-54% -$1.09M ﹤0.01% 2010
2021
Q3
$2.08M Sell
22,524
-8,666
-28% -$801K ﹤0.01% 1467
2021
Q2
$2.43M Buy
31,190
+572
+2% +$44.5K ﹤0.01% 1363
2021
Q1
$2.28M Buy
30,618
+18,301
+149% +$1.36M 0.01% 1325
2020
Q4
$2.1M Buy
12,317
+310
+3% +$52.9K 0.01% 1265
2020
Q3
$1.69M Buy
12,007
+870
+8% +$122K ﹤0.01% 1259
2020
Q2
$1.79M Sell
11,137
-792
-7% -$127K 0.01% 1167
2020
Q1
$1.17M Sell
11,929
-1,720
-13% -$168K 0.01% 1122
2019
Q4
$1.76M Sell
13,649
-1,770
-11% -$228K 0.01% 1226
2019
Q3
$1.16M Sell
15,419
-346
-2% -$26.1K ﹤0.01% 1384
2019
Q2
$2.4M Sell
15,765
-1,389
-8% -$211K 0.01% 1004
2019
Q1
$2.05M Buy
17,154
+4,642
+37% +$553K 0.01% 1057
2018
Q4
$1.37M Buy
12,512
+852
+7% +$92.9K 0.01% 1109
2018
Q3
$1.88M Sell
11,660
-592
-5% -$95.6K 0.01% 1117
2018
Q2
$1.62M Buy
12,252
+131
+1% +$17.3K 0.01% 1144
2018
Q1
$898K Sell
12,121
-6,518
-35% -$483K 0.01% 1369
2017
Q4
$1.04M Sell
18,639
-8,957
-32% -$498K 0.01% 1281
2017
Q3
$1.25M Buy
27,596
+6,725
+32% +$305K 0.01% 1163
2017
Q2
$704K Buy
20,871
+9,635
+86% +$325K ﹤0.01% 1478
2017
Q1
$333K Buy
11,236
+3,173
+39% +$94K ﹤0.01% 1837
2016
Q4
$221K Sell
8,063
-2,898
-26% -$79.4K ﹤0.01% 1997
2016
Q3
$673K Buy
+10,961
New +$673K 0.01% 1328